Dr. Jacy Villa, MD

Dr. Villa practices at Hematology and Medical Oncology of Southern Palm Beach County Inc in Boynton Beach, Florida.

Dr. Villa's NPI, 1811995434, was assigned on July 8, 2005. Dr. Villa graduated from Faculdade de Medicina da Universidade Federal do Rio de Janeiro in 1989. Dr. Villa holds Florida license ME80441.

Dr. Villa's primary practice is Hematology and Medical Oncology of Southern Palm Beach County Inc, at 2623 S Seacrest Blvd, Boynton Beach, FL 33435 in Palm Beach County. The practice phone is (561) 742-0065.

Dr. Villa's primary practice is Hematology and Medical Oncology of Southern Palm Beach County Inc in Boynton Beach, Florida. Dr. Villa is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Villa to 3 more hospitals, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Villa practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Villa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Villa is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Villa's licenses on file in 3 states: Florida, New Hampshire and North Carolina.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Villa treats.

CMS data shows 357 Medicare services from Dr. Villa across 4 procedure codes in 2024, all of them office visits, for 180 Medicare patients. Medicare paid $25,896 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. Villa in 2024. The largest group is 75 to 84, with 73 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Villa's median patient age at 69, with 60% women.

In 2024, Dr. Villa wrote 349 Medicare Part D claims for 74 patients. 74% of them were for generic drugs. CMS names the drug for 209 of them, across 12 drugs with 11 or more claims each, at $482,404 in total drug cost. In 2023, CMS named 210 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Villa for performance year 2024, reported through an alternative payment model (APM). Dr. Villa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Villa as offering telehealth.

Dmand AI links 3 papers to Dr. Villa. The most frequent topics are Axl Receptor Tyrosine Kinase, Intercellular Signaling Peptides and Proteins and Oncogene Proteins. Dr. Villa has published most often in J Biol Chem.

CMS Open Payments shows 174 general payments to Dr. Villa from 29 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $623.

Dr. Villa graduated from Faculdade de Medicina da Universidade Federal do Rio de Janeiro in 1989.

Dr. Villa is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.